Health and Fitness Health and Fitness
Mon, November 21, 2011
[ Mon, Nov 21st 2011 ] - Market Wire
BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index
[ Mon, Nov 21st 2011 ] - Market Wire
REVLIMID riceve approvazione di Swissmedic per il trattamento di un raro cancro del sangue
[ Mon, Nov 21st 2011 ] - Market Wire
REVLIMID Granted Swissmedic Approval for Treatment of Rare Blood Cancer
[ Mon, Nov 21st 2011 ] - Market Wire
BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
[ Mon, Nov 21st 2011 ] - Market Wire
ArthroCare Announces Participation in Investor Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer(TM) Explosives .. New Mobile Airfreight Screening Business in Germa
[ Mon, Nov 21st 2011 ] - Market Wire
Oncolytics Biotech Inc. Announces Start of Conformity Testing with SAFC
[ Mon, Nov 21st 2011 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot
[ Mon, Nov 21st 2011 ] - Market Wire
Adeona Pharmaceuticals and Intrexon Announce Worl .. for Synthetic DNA-based Therapy for Pulmonary Ar
[ Mon, Nov 21st 2011 ] - Market Wire
Preclinical Darinaparsin Study in PLoS ONE Publication
[ Mon, Nov 21st 2011 ] - Market Wire
Health Management Associates, Inc. Announces Clos .. ties, Private $875 Million Debt Offering and GAAP
[ Mon, Nov 21st 2011 ] - Market Wire
OncoSec Appoints Scientific Advisory Board
[ Mon, Nov 21st 2011 ] - Market Wire
Alnylam Presents Positive Preliminary Clinical Re .. Therapeutic for the Treatment of Transthyretin-Me
[ Mon, Nov 21st 2011 ] - Market Wire
Perceptive Informatics Global Survey Results Indi .. ndard Medical Imaging Metrics to Meet Study Miles
[ Mon, Nov 21st 2011 ] - Market Wire
PowerVerde Announces Binding Letter of Intent to .. tion Group, a Technology and Distribution Company
[ Mon, Nov 21st 2011 ] - Market Wire
Exelixis Announces Initiation of Phase 2 Investig .. antinib in Women with Hormone Receptor-Positive M
[ Mon, Nov 21st 2011 ] - Market Wire
Comprehensive Care Corporation Announces Nine Month Revenues Top $54 Million, up 212 Percent
Sun, November 20, 2011
[ Sun, Nov 20th 2011 ] - Market Wire
Valeant Pharmaceuticals Agrees to Acquire iNova
[ Sun, Nov 20th 2011 ] - Market Wire
CML HealthCare Inc. Declares November Dividend
Fri, November 18, 2011
[ Fri, Nov 18th 2011 ] - Market Wire
Warnex Reaches Agreement to Extend Maturity Date .. ing Debentures and to Obtain Additional Financing
[ Fri, Nov 18th 2011 ] - Market Wire
Quidel to Present at 23rd Annual Piper Jaffray Health Care Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Regeneron Announces FDA Approval of EYLEAa" (afli .. Treatment of Wet Age-Related Macular Degeneration
[ Fri, Nov 18th 2011 ] - Market Wire
Cigna Announces Leadership Changes
[ Fri, Nov 18th 2011 ] - Market Wire
Orthofix International to Participate in the 23rd Annual Piper Jaffray Healthcare Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates Chemed Corp.
[ Fri, Nov 18th 2011 ] - Market Wire
Steps in the Right Direction - Featured Research .. ign Technology, Inc. and IDEXX Laboratories, Inc.
[ Fri, Nov 18th 2011 ] - Market Wire
Tibet Pharmaceuticals Announces Availability of Third Quarter 2011 Earnings Call Transcript
[ Fri, Nov 18th 2011 ] - Market Wire
Daxor Corporation Announces Intention to Register .. Company Under the Investment Company Act of 1940
[ Fri, Nov 18th 2011 ] - Market Wire
Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference

Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference


Published on 2011-11-18 05:36:54 - Market Wire
  Print publication without navigation


Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference -- NATICK, Mass., Nov. 18, 2011 /PRNewswire/ --

Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference

[ ]

NATICK, Mass., Nov. 18, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: [ BSX ]) is scheduled to participate in the Piper Jaffray 23rd Annual Healthcare Conference on November 30 in New York.

Jeff Capello, Executive Vice President and Chief Financial Officer, will participate in a 30-minute question and answer session regarding the Company beginning at approximately 9:00 a.m. ET.

A live webcast of the question and answer session will be available to all interested parties via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at [ www.bostonscientific.com/investors ].  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Piper Jaffray.  The replay will be archived and available at [ www.bostonscientific.com/investors ] beginning approximately one hour following the completion of the session.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: [ www.bostonscientific.com ].   

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

CONTACT:

Eric Olson

 

336-293-4393 (office)

 

Media Relations

 

Boston Scientific Corporation

 

[ eric.olson@bsci.com ]

 

 

 

 

Sean Wirtjes

 

508-652-5305 (office)

 

Investor Relations

 

Boston Scientific Corporation

 

[ investor_relations@bsci.com ]

 

SOURCE Boston Scientific Corporation

[ Back to top ]

RELATED LINKS
[ http://www.bostonscientific.com ]

Contributing Sources